Crossmark

Considerations regarding a meta-analysis of ceftazidime-avibactam versus other antimicrobial agents for treatment of multidrug-resistant pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1007/s15010-024-02458-9

Published Online: 2024-12-18

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Feng

Pang, Huayang

Li, Chunxue
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 2 September 2024

Accepted: 16 December 2024

First Online: 18 December 2024

Declarations

:

: The authors declare no competing interests.

: No need for this letter to the editor.

: The authors have no competing interests to declare.

Document is current

Any future updates will be listed below